Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis.

The proteolytic modification of plasminogen activator inhibitor 2 (PAI-2) was studied during apoptosis in the human promyelocytic leukaemic NB4 cell line during treatment with the phosphatase inhibitors okadaic acid and calyculin A as well as the protein synthesis inhibitor cycloheximide. The apopti...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, P. H., Cressey, L. I., Gjertsen, B. T., Madsen, P., Mellgren, G., Hokland, P., Gliemann, J., Døskeland, S. O., Lanotte, M., Vintermyr, O. K.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033559/
https://www.ncbi.nlm.nih.gov/pubmed/7947088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033559/
https://www.ncbi.nlm.nih.gov/pubmed/7947088

Ejemplares similares